Letter: the efficacy of interferon‐free regimens in HCV‐related Child C cirrhosis needs careful interpretation

Abstract

Linked ContentThis article is linked to Guarino et al and Andriulli et al papers. To view these articles visit https://doi.org/10.1111/apt.14017 and https://doi.org/10.1111/apt.14099.

Letter: the efficacy of interferon‐free regimens in HCV‐related Child C cirrhosis needs careful interpretation―Authors' reply

“…We are very much indebted to Drs Rezaee-Zavareh and Alavian for the attention they paid to our manuscript. 1,2 We share their concern about the need to provide comprehensive evidences supporting the value of the administration of the new direct-acting antivirals (DAAs) in HCV-infected patients with liver cirrhosis staged in Child C class. Unfortunately, no single study has been so far devoted to this very problematic setting of patients, and what we did was to retrieve information on these patients enrolled in previous studies.…”